Decatur Capital Management, Inc. United Therapeutics Corp Transaction History
Decatur Capital Management, Inc.
- $218 Million
- Q4 2024
A detailed history of Decatur Capital Management, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Decatur Capital Management, Inc. holds 9,208 shares of UTHR stock, worth $3.41 Million. This represents 1.49% of its overall portfolio holdings.
Number of Shares
9,208Holding current value
$3.41 Million% of portfolio
1.49%Shares
1 transactions
Others Institutions Holding UTHR
# of Institutions
719Shares Held
60.7MCall Options Held
181KPut Options Held
158K-
Wealthfront Advisers LLC18.3MShares$6.79 Billion5.38% of portfolio
-
Black Rock Inc. New York, NY5.47MShares$2.03 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.65 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$1.02 Billion14.19% of portfolio
-
Wellington Management Group LLP Boston, MA2.46MShares$913 Million0.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.9B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...